Jacobs & Co. CA Sells 1,668 Shares of The Procter & Gamble Company (NYSE:PG)

Jacobs & Co. CA lessened its stake in shares of The Procter & Gamble Company (NYSE:PG) by 3.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 40,691 shares of the company’s stock after selling 1,668 shares during the period. Jacobs & Co. CA’s holdings in Procter & Gamble were worth $6,821,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Concurrent Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares during the last quarter. Copley Financial Group Inc. purchased a new stake in Procter & Gamble in the 3rd quarter worth about $668,000. Fortem Financial Group LLC purchased a new stake in Procter & Gamble in the 4th quarter worth about $569,000. Synovus Financial Corp increased its position in shares of Procter & Gamble by 3.4% during the third quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after acquiring an additional 6,077 shares during the period. Finally, Nordea Investment Management AB increased its position in shares of Procter & Gamble by 7.5% during the fourth quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock worth $484,583,000 after acquiring an additional 201,695 shares during the period. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In related news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This represents a 52.53 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,439 shares of company stock worth $13,317,460. 0.18% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a research report on Tuesday. Piper Sandler assumed coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. DA Davidson reaffirmed a “buy” rating and set a $209.00 target price on shares of Procter & Gamble in a research report on Friday, December 27th. Evercore ISI lifted their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. Finally, Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a report on Monday, September 30th. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $179.75.

Procter & Gamble Stock Performance

PG traded down $4.58 on Friday, reaching $157.52. The stock had a trading volume of 4,299,350 shares, compared to its average volume of 6,154,908. The company has a market cap of $370.97 billion, a P/E ratio of 27.16, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The business’s 50-day moving average price is $169.77 and its two-hundred day moving average price is $169.64. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 12-month low of $146.28 and a 12-month high of $180.43.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.83 earnings per share. Sell-side analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.